Bernard Cerutti Selected Research

Sleep-Wake Transition Disorders (Sleep Talking)

3/2019	A prospective observational study of the main features of nocturnal leg cramps in primary care.
2/2014	Effect of magnesium therapy on nocturnal leg cramps: a systematic review of randomized controlled trials with meta-analysis using simulations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernard Cerutti Research Topics

Disease

2	Hemorrhage 01/2022 - 08/2007
2	Sleep-Wake Transition Disorders (Sleep Talking) 03/2019 - 02/2014
2	Critical Illness (Critically Ill) 02/2012 - 08/2007
1	Muscle Cramp (Cramp) 03/2019
1	Measles 04/2016
1	Hepatitis B 04/2016
1	Tetanus 04/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Liver Failure 02/2012
1	Infections 02/2012
1	Bacteremia 02/2012
1	Communicable Diseases (Infectious Diseases) 04/2011
1	Vascular Diseases (Vascular Disease) 10/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2009
1	Hypertension (High Blood Pressure) 08/2007
1	Pain (Aches) 08/2007
1	Tachycardia (Tachyarrhythmias) 08/2007
1	Acute Coronary Syndrome 08/2007

Drug/Important Bio-Agent (IBA)

2	MagnesiumIBA 03/2019 - 02/2014
1	phytobacteriomycin (PBM)IBA 01/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 03/2019
1	antineoplaston A10 (A 10)IBA 03/2019
1	AntibodiesIBA 04/2016
1	Tenofovir (Viread)FDA Link 01/2014
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2014
1	NucleosidesIBA 01/2014
1	ProcalcitoninIBA 02/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2012
1	Illicit Drugs (Recreational Drugs)IBA 04/2011
1	Pharmaceutical PreparationsIBA 10/2009
1	Hemoglobins (Hemoglobin)IBA 08/2007
1	Nitroglycerin (Dynamite)FDA LinkGeneric 08/2007

Therapy/Procedure

2	Therapeutics 02/2014 - 02/2012
1	Art Therapy 01/2016
1	Length of Stay 02/2012
1	Secondary Prevention 10/2009
1	Intravenous Administration 08/2007